MMWR. Morbidity and Mortality Weekly Report / Vol.75 / No.6 / February 19, 2026

Details

• Alternative Title:
  COVID-19 Antiviral Prescription Receipt Among Outpatients Aged ≥65 Years — United States, June 1, 2023–September 30, 2025 ; Respiratory Virus Activity — United States, July 1, 2024–June 30, 2025 ; Regional Increases in Incidence of Coccidioidomycosis (Valley Fever) — Arizona, 2005–2022
• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  Epidemiological notes on specified notifiable diseases in the United States. This issue includes discussions of covid-19, antiviral agents, respiratory syncytial viruses, and coccidioidomycosis.
• Subjects:
  Antiviral Agents Coccidioidomycosis Communicable Diseases Covid-19 Disease Notification Mortality Respiratory Syncytial Viruses
• Source:
  Morbidity and Mortality Weekly Report (MMWR), 2026; v. 75, no. 6
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 ; 1545-861X
• Document Type:
  Text
• Genre:
  Journal Issue
• Place as Subject:
  United States
• Pages in Document:
  24 pdf pages
• Volume:
  75
• Issue:
  6
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:d652f5a64f5706edafcfbd3d7bb19b71eb02e3c2d71c848d06694b361a434693986f08728c729aaa9e332f5b4ae5883073f14756e18c3235ca7e2030bef13173
• Download URL:
  https://stacks.cdc.gov/view/cdc/252307/cdc_252307_DS1.pdf
• File Type:
  [PDF - 1.02 MB ]